格拉尼尔格拉尼尔二酸盐合成酶抑制会损害骨质细胞分化,形态和吸收活性
Molly E Muehlebach1, Staci L Haney2, Yashpal S Chhonker3
1Cancer Research Doctoral Program, University of Nebraska Medical Center, Omaha, NE 68198, United States.
JBMR plus
|December 19, 2024
概括
一种新的GGDPS抑制剂RAM2061通过破坏骨质细胞的形成和功能来显示抗骨质细胞活性. 这一发现支持探索GGDPS抑制剂用于病理性骨重塑疾病.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 二酸针对骨解性骨病的FDPS,但分布有限.
- 像RAM2061这样的Geranylgeranyl二酸盐合成酶 (GGDPS) 抑制剂提供了改善的类似药物的特性和抗瘤作用.
- 研究RAM2061对骨质细胞生物学的影响对于了解其在骨疾病中的治疗潜力至关重要.
研究的目的:
- 评估RAM2061对骨质细胞生物学和骨重塑的影响.
- 为了确定GGDPS抑制是否影响骨质细胞分化,功能和生存.
- 评估RAM2061.1.的体内骨向性和抗骨折潜力.
主要方法:
- 使用RAW264.7细胞进行体外研究,以评估GGDPS抑制,蛋白质geranylgeranylation,未折叠的蛋白质反应和亡.
- 分析骨质细胞分化,形态,耐酸酸酶活性和吸收活性.
- 同焦显微镜检查actin环形成和Cdc42定位.
- 在体内对CD-1小鼠进行研究,以评估骨循环标志物和组织形态学.
- 液体染色学-双重质谱法用于骨和酸结合中的药物积累.
主要成果:
- 在RAM2061治疗中耗尽了geranylgeranyl二酸盐,蛋白质geranylgeranylation受损,并在未分化的细胞中诱导了亡.
- 骨质细胞分化被抑制,导致较少的成熟骨质细胞具有改变的形态和减少的酸盐抗酸酸酶活性.
- 通过抑制Cdc42局部化,RAM2061降低了骨质细胞吸收活性,并破坏了活性环的形成.
- 在体内研究表明,RAM2061在骨和酸结合中的积累,骨质细胞数量减少,但在3周内骨周转率标志物或组织形态学没有显著变化.
- 这些研究是首次证明GGDPS抑制剂治疗的抗骨质结晶活性.
结论:
- 通过抑制骨质细胞分化和功能,RAM2061在体外表现出显著的抗骨质细胞活性.
- 该药物在体内表现出向骨的特性,有证据表明骨质细胞数量减少.
- 这些发现支持进一步研究GGDPS抑制剂,如RAM2061,作为病理性骨改造的潜在治疗策略.
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
GPCR Desensitization
5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K


